| 2022 | Teran LM: Allergen Immunotherapy: Current and Future Trends.. In: Cells, 8, 2022, 212 |
|---|
| 2022 | Pavón-Romero GF, Calderón-Ezquerro MDC, Rodríguez-Cervantes MA, Fernández-Villanueva D, Melgoza-Ruiz E, Ramírez-Jiménez F, Teran LM.: Association of Allergic Sensitivity and Pollination in Allergic Respiratory Disease: The Role of Pollution.. In: J Asthma Allergy., 1, 2022, 1227-1243 |
|---|
| 2022 | Vizuet-de-Rueda JC, Montero-Vargas JM, Galván-Morales MÁ, Porras-Gutiérrez-de-Velasco R, Teran LM.: Current Insights on the Impact of Proteomics in Respiratory Allergies.. In: Int J Mol Sci., 20, 2022, 5703 |
|---|
| 2022 | Huerta-Ocampo JÁ, Batista-Roche LG, Morales-Amparano MB, Robles-Burgueño MDR, Ramos-Clamont Montfort G, Vázquez-Moreno L, Ramírez-Jiménez F, Terán LM.: Identification of Allergenic Proteins in Velvet Mesquite (Prosopis velutina) Pollen: An Immunoproteomics Approach.. In: Life (Basel), 13, 2022, 1421 |
|---|
| 2021 | Ramírez-Jiménez F, Vázquez-Corona A, Sánchez-de la Vega Reynoso P, Pavón-Romero GF, Jiménez-Chobillon MA, Castorena-Maldonado AR, Teran LM.: Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.. In: J Allergy Clin Immunol Pract., 9, 2021, 1554-1561 |
|---|
| 2021 | Teran LM: Immunoproteomic identification of allergenic proteins in pecan (Carya illinoinensis) pollen.. In: J Proteomics, 30, 2021, 104348 |
|---|
| 2021 | Teran LM: Neuroimmune Pathophysiology in Asthma.. In: Front Cell Dev Biol, doi: 10.3389/fcell.2021.663535, 2021, doi: 10.3389/fcell.2021.663535 |
|---|
| 2021 | Teran LM: New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.. In: nt J Mol Sci, 2, 2021, 11898 |
|---|
| 2021 | Pavon-Romero GF, Larenas-Linnemann DE, Xochipa Ruiz KE, Ramirez-Jimenez F, Teran LM.: Subcutaneous Allergen-Specific Immunotherapy Is Safe in Pediatric Patients with Allergic Rhinitis.. In: Int Arch Allergy Immunol., 182, 2021, 553-561 |
|---|
| 2021 | Teran LM: The Role of Enolases in Allergic Disease.. In: J Allergy Clin Immunol Pract., 9, 2021, 3026-3032 |
|---|
| 2021 | Priyadharshini VS, Jiménez-Chobillon MA, de Graaf J, Porras Gutiérrez de Velasco R, Gratziou C, Ramírez-Jiménez F, Teran LM.: Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD).. In: Biomolecules., 11, 2021, 1092 |
|---|
| 2020 | Pavón-Romero GF, Pérez-Rubio G, Ramírez-Jiménez F, Ambrocio-Ortiz E, Merino-Camacho CR, Falfán-Valencia R, Teran LM.: IL10 rs1800872 Is Associated with Non-Steroidal Anti-Inflammatory Drugs Exacerbated Respiratory Disease in Mexican-Mestizo Patients.. In: Biomolecules, 7, 2020, 104 |
|---|
| 2020 | Teran LM: Ligustrum pollen: New insights into allergic disease.. In: World Allergy Organ J., 5, 2020, 100104 |
|---|
| 2020 | Teran LM: Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy.. In: Molecules., 2, 2020, 5686 |
|---|
| 2020 | Pavón-Romero GF, Ramírez-Jiménez F, Roldán-Alvarez MA, Terán LM, Falfán-Valencia R.: Physiopathology and genetics in aspirin-exacerbated respiratory disease.. In: Exp Lung Res, 43, 2020, 327-335 |
|---|
| 2020 | Huerta-Ocampo JÁ, Valenzuela-Corral A, Robles-Burgueño MDR, Guzmán-Partida AM, Hernández-Oñate MÁ, Vázquez-Moreno L, Pavón-Romero GF, Terán LM.: Proteomic identification of allergenic proteins in red oak (Quercus rubra) pollen.. In: World Allergy Organ J. 17, 2020, doi: 10.1016/j.waojou.2020.100111 |
|---|
| 2018 | Teran LM: Aspirin exacerbated respiratory disease: Current topics and trends.. In: Respir Med, 1, 2018, 62-75 |
|---|
| 2018 | avón-Romero GF, Pérez-Rubio G, Ramírez-Jiménez F, Ambrocio-Ortiz E, Bañuelos-Ortiz E, Alvarado-Franco N, Xochipa-Ruiz KE, Hernández-Juárez E, Flores-García BA, Camarena ÁE, Terán LM, Falfán-Valencia R.: MS4A2-rs573790 Is Associated With Aspirin-Exacerbated Respiratory Disease: Replicative Study Using a Candidate Gene Strategy.. In: Front Genet., 11, 2018, doi: 10.3389/fgene.2018.00363. eCollection 2018. |
|---|
| 2018 | Cardona EEG, Heathcote K, Teran LM, Righetti PG, Boschetti E, D'Amato A.: Novel low-abundance allergens from mango via combinatorial peptide libraries treatment: A proteomics study.. In: Food Chem., 15, 2018, 652-660 |
|---|
| 2017 | Teran LM, Ramirez-Jimenez F, Soid-Raggi G, Velazquez JR.: Interleukin 16 and CCL17/thymus and activation-regulated chemokine in patients with aspirin-exacerbated respiratory disease.. In: Ann Allergy Asthma Immunol, 118, 2017, 191-196 |
|---|
| 2017 | Pavón-Romero GF, Reséndiz-Hernández JM, Ramírez-Jiménez F, Pérez-Rubio G, Camarena Á, Terán LM, Falfán-Valencia R.: Single nucleotide polymorphisms in TNF are associated with susceptibility to aspirin-exacerbated respiratory disease but not to cytokine levels: a study in Mexican mestizo population.. In: Biomark Med., 11, 2017, 1047-1055 |
|---|
| 2016 | Narayanankutty A, Palma-Lara I, Pavón-Romero G, Pérez-Rubio G, Camarena Á, Teran LM, Falfán-Valencia R.: Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD).. In: Lung, 194, 2016, 273-279 |
|---|
| 2016 | Landa-Pineda CM, Arroyo-Becerra A, Rosas-Alvarado A, Terán LM, Garcia-Cruz ML, Marchat LA, Reyes-López CA.: Major allergen from Amaranthus palmeri pollen is a profilin: Isolation, partial characterisation and IgE recognition.. In: Allergol Immunopathol (Madr)., 44, 2016, 160-166 |
|---|
| 2016 | Teran LM: Personalized Medicine in Respiratory Disease: Role of Proteomics.. In: Adv Protein Chem Struct Biol., 1, 2016, 115-156 |
|---|
| 2015 | Mani BM, Huerta-Ocampo JA, Garcia-Sanchez JR, Barrera-Pacheco A, de la Rosa AP, Teran LM.: Identification of Ligustrum lucidum pollen allergens using a proteomics approach.. In: Biochem Biophys Res Commun., 468, 2015, 788-792 |
|---|
| 2015 | Teran LM: Respiratory proteomics: from descriptive studies to personalized medicine.. In: J Proteome Res., 2, 2015, 38-50 |
|---|
| 2013 | Velazquez JR, Teran LM.: Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.. In: Clin Rev Allergy Immunol., 45, 2013, 75-86 |
|---|
| 2013 | Narayanankutty A, Reséndiz-Hernández JM, Falfán-Valencia R, Teran LM.: Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD).. In: Clin Biochem., 45, 2013, 566-578 |
|---|
| 2012 | Teran LM: Air pollution: impact and prevention.. In: Respirology., 17, 2012, 1031-1038 |
|---|
| 2012 | Teran LM: Aspirin exacerbated respiratory disease.. In: J Allergy (Cairo). doi: 10.1155/2012/473863., 2012, doi: 10.1155/2012/473863. |
|---|
| 2012 | Arshad SH, Dharmage SC, Ferreira F, Fixman ED, Gadermaier G, Hauser M, Sampson AP, Teran LM, Wallner M, Wardlaw AJ.: Developments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy.. In: Clin Exp Allergy., 42, 2012, 1697-1723 |
|---|
| 2012 | Teran LM, Rüggeberg S, Santiago J, Fuentes-Arenas F, Hernández JL, Montes-Vizuet AR, Xinping L, Franz T.: Immune response to seasonal influenza A virus infection: a proteomic approach.. In: Arch Med Res., 43, 2012, 464-469 |
|---|
| 2012 | Garcia Cruz ML, Jimenez-Chobillon MA, Teran LM.: Rhinosinusitis and aspirin-exacerbated respiratory disease.. In: J Allergy (Cairo). doi: 10.1155/2012/273752, 2012, doi: 10.1155/2012/273752 |
|---|
| 2012 | Baay-Guzman GJ, Huerta-Yepez S, Vega MI, Aguilar-Leon D, Campillos M, Blake J, Benes V, Hernandez-Pando R, Teran LM.: Role of CXCL13 in asthma: novel therapeutic target.. In: Chest, 141, 2012, 886-894 |
|---|
| 2012 | Falfán-Valencia R, Pavón-Romero GF, Camarena A, García Mde L, Galicia-Negrete G, Negrete-García MC, Teran LM.: The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population.. In: J Allergy (Cairo)., doi: 10.1155/2012/741313. Epub 2011 Nov 3., 2012, doi: 10.1155/2012/741313. Epub 2011 Nov 3. |
|---|
| 2011 | Velazquez JR, Teran LM.: Chemokines and their receptors in the allergic airway inflammatory process.. In: Clin Rev Allergy Immunol, 41, 2011, 76-88 |
|---|
| 2011 | Guaní-Guerra E, Negrete-García MC, Montes-Vizuet R, Asbun-Bojalil J, Terán LM.: Human β-defensin-2 induction in nasal mucosa after administration of bacterial lysates.. In: Arch Med Res., 42, 2011, 189-194 |
|---|
| 2010 | Godina-Gonzalez S, Furuzawa-Carballeda J, Utrera-Barillas D, Alcocer-Varela J, Teran LM, Vazquez-del Mercado M, Leal YA, Alvarado-Cabrero I, Velazquez JR.: Amebic monocyte locomotion inhibitory factor peptide ameliorates inflammation in CIA mouse model by downregulation of cell adhesion, inflammation/chemotaxis, and matrix metalloproteinases genes.. In: Inflamm Res., 59, 2010, 1041-1051 |
|---|
| 2010 | Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM.: Antimicrobial peptides: general overview and clinical implications in human health and disease.. In: Clin Immunol., 135, 2010, 1-11 |
|---|
| 2010 | Duemmler A, Montes-Vizuet AR, Cruz JS, Terán LM.: CXCL5 into the upper airways of children with influenza A virus infection.. In: Rev Med Inst Mex Seguro Soc., 48, 2010, 393-398 |
|---|
| 2010 | Negrete-García MC, Velazquez JR, Popoca-Coyotl A, Montes-Vizuet AR, Juárez-Carvajal E, Teran LM.: Chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 is associated with leukocyte recruitment in asthma.. In: Chest., 138, 2010, 100-106 |
|---|
| 2010 | Zepeda-Lopez HM, Perea-Araujo L, Miliar-García A, Dominguez-López A, Xoconostle-Cázarez B, Lara-Padilla E, Ramírez Hernandez JA, Sevilla-Reyes E, Orozco ME, Ahued-Ortega A, Villaseñor-Ruiz I, Garcia-Cavazos RJ, Teran LM.: Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico.. In: PLoS One., 5, 2010, doi: 10.1371/journal.pone.0013256. |
|---|
| 2009 | Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, Negrete-García MC, García-Cruz Mde L, Teran LM.: Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.. In: Clin Exp Allergy., 39, 2009, 491-499 |
|---|
| 2009 | Teran LM: [Allergy, pollen and the environment].. In: Gac Med Mex., 145, 2009, 215-222 |
|---|
| 2008 | Santiago J, Hernández-Cruz JL, Manjarrez-Zavala ME, Montes-Vizuet R, Rosete-Olvera DP, Tapia-Díaz AM, Zepeda-Peney H, Terán LM.: Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma.. In: Eur Respir J., 32, 2008, 1243-1249 |
|---|
| 2006 | Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, Negrete-García MC, Velásquez JR, Teran LM.: CC chemokine ligand 1 is released into the airways of atopic asthmatics.. In: Eur Respir J., 28, 2006, 59-67 |
|---|
| 2006 | Terán LM, Ledesma-Soto Y, Krengel S, Lezcano-Meza D.: [The role of eotaxins in bronchial asthma and nasal polyposis].. In: Gac Med Mex., 142, 2006, 139-144 |
|---|
| 2003 | Utrera-Barillas D, Velazquez JR, Enciso A, Cruz SM, Rico G, Curiel-Quesada E, Teran LM, Kretschmer RR.: An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines.. In: Parasite Immunol., 25, 2003, 475-482 |
|---|
| 2003 | Lezcano-Meza D, Dávila-Dávila B, Vega-Miranda A, Negrete-García MC, Teran LM.: Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps.. In: Allergy., 58, 2003, 1011-1017 |
|---|
| 2003 | Rojas-Ramos E, Avalos AF, Pérez-Fernandez L, Cuevas-Schacht F, Valencia-Maqueda E, Terán LM.: Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma.. In: Eur Respir J., 22, 2003, 310-316 |
|---|
| 2003 | Meyer-Hoffert U, Lezcano-Meza D, Bartels J, Montes-Vizuet AR, Schröder JM, Teran LM.: Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells.. In: Int Arch Allergy Immunol., 131, 2003, 264-271 |
|---|
| 2003 | Lezcano-Meza D, Negrete-Garcia MC, Dante-Escobedo M, Teran LM.: The monocyte-derived chemokine is released in the bronchoalveolar lavage fluid of steady-state asthmatics.. In: Allergy., 58, 2003, 1125-1130 |
|---|
| 2001 | Sandoval-López G, Teran LM.: TARC: novel mediator of allergic inflammation.. In: Clin Exp Allergy., 31, 2001, 1809-1812 |
|---|
| 2000 | Luis M. Teran: CCL chemokines and asthma. In: Immunol Today, 2000, 235 |
|---|
| 2000 | Teran LM: CCL chemokines and asthma.. In: Immunol Today., 21, 2000, 235-242 |
|---|
| 2000 | Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM.: Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. In: Am J Respir Cell Mol Biol., 22, 2000, 714-721 |
|---|
| 2000 | J. Harder, U. Meyer-Hoffert, Luis M. Teran, L. Schwichtenberg, J. Bartels, S. Maune, J. M. Schroder: Mucoid pseudomonas aeruginosa, TNF-alpha, and IL beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelial . In: Am J. Respir Cell Mol Biol, 2000, 714-721 |
|---|
| 2000 | Papi A, Stanciu LA, Papadopoulos NG, Teran LM, Holgate ST, Johnston SL.: Rhinovirus infection induces major histocompatibility complex class I and costimulatory molecule upregulation on respiratory epithelial cells. In: J Infect Dis, 181, 2000, 1780-1784 |
|---|
| 1999 | K. J. Bodey, A. E. Samper, J. Maddel, Luis M. Teran, S. T. Holgate, A. J. Frew: Cytokine profiles of BAL T-cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. In: Allergy, 1999, 1083 |
|---|
| 1996 | Luis M. Teran, N. Noso, M. Carroll, D. E. Davies, S. T. Holgate, J. M. Schröder: Eosinophil recuitment following endobronchial allergen challenge is associated with the release of RANTES into asthmatic airways. In: J. Immunol, 1996, 1806-1812 |
|---|
| Luis M. Teran, et al.: Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. In: Clin Exp Allergy, , 396-405 |
|---|
